Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

医学 脂肪肝 危险系数 内科学 疾病 比例危险模型 死亡风险 死因 死亡率 脂肪变性 置信区间
作者
Donghee Kim,Peter Konyn,Keeryth K. Sandhu,Brittany B. Dennis,Amanda Cheung,Aijaz Ahmed
出处
期刊:Journal of Hepatology [Elsevier]
卷期号:75 (6): 1284-1291 被引量:284
标识
DOI:10.1016/j.jhep.2021.07.035
摘要

•Metabolic dysfunction-associated fatty liver disease (MAFLD) was associated with increased all-cause and cardiovascular mortality. •NAFLD was associated with increased all-cause mortality among individuals with known metabolic risk factors. •Advanced fibrosis in MAFLD was associated with higher estimates for all-cause mortality than in NAFLD. Background & Aims Recently, international experts proposed redefining non-alcoholic fatty liver disease (NAFLD) as metabolic dysfunction-associated fatty liver disease (MAFLD), based on modified criteria. It is suspected that outcomes such as mortality may differ for these clinical entities. We studied the impact of MAFLD and NAFLD on all-cause and cause-specific mortality in US adults. Methods We analyzed data from 7,761 participants in the Third National Health and Nutrition Examination Survey and their linked mortality through 2015. NAFLD was diagnosed by ultrasonographic evidence of hepatic steatosis without other known liver diseases. MAFLD was defined based on the criteria proposed by an international expert panel. The Cox proportional hazard model was used to study all-cause mortality and cause-specific mortality between MAFLD and NAFLD, with adjustments for known risk factors. Results During a median follow-up of 23 years, individuals with MAFLD had a 17% higher risk of all-cause mortality (hazard ratio [HR] 1.17; 95% CI 1.04-1.32). Furthermore, MAFLD was associated with a higher risk of cardiovascular mortality. NAFLD per se did not increase the risk of all-cause mortality. Individuals who met both definitions had a higher risk of all-cause mortality (HR 1.13, 95% CI 1.00-1.26), while individuals who met the definition for MAFLD but not NAFLD had a 1.7-fold higher risk of all-cause mortality (HR 1.66, 95% CI 1.19-2.32). Estimates for all-cause mortality were higher for those with advanced fibrosis and MAFLD than for those with advanced fibrosis and NAFLD. Conclusions In this US population-based study, MAFLD was associated with an increased risk of all-cause mortality, while NAFLD demonstrated no association with all-cause mortality after adjusting for metabolic risk factors. Lay summary Our findings provide further support for the idea that non-alcoholic fatty liver disease (NAFLD) is a part of a broader multi-system disease that also includes obesity, diabetes, high blood pressure, and high cholesterol. Therefore, re-defining NAFLD as metabolic dysfunction-associated fatty liver disease (MAFLD) may help improve our understanding of predictors that increase the risk of death. Recently, international experts proposed redefining non-alcoholic fatty liver disease (NAFLD) as metabolic dysfunction-associated fatty liver disease (MAFLD), based on modified criteria. It is suspected that outcomes such as mortality may differ for these clinical entities. We studied the impact of MAFLD and NAFLD on all-cause and cause-specific mortality in US adults. We analyzed data from 7,761 participants in the Third National Health and Nutrition Examination Survey and their linked mortality through 2015. NAFLD was diagnosed by ultrasonographic evidence of hepatic steatosis without other known liver diseases. MAFLD was defined based on the criteria proposed by an international expert panel. The Cox proportional hazard model was used to study all-cause mortality and cause-specific mortality between MAFLD and NAFLD, with adjustments for known risk factors. During a median follow-up of 23 years, individuals with MAFLD had a 17% higher risk of all-cause mortality (hazard ratio [HR] 1.17; 95% CI 1.04-1.32). Furthermore, MAFLD was associated with a higher risk of cardiovascular mortality. NAFLD per se did not increase the risk of all-cause mortality. Individuals who met both definitions had a higher risk of all-cause mortality (HR 1.13, 95% CI 1.00-1.26), while individuals who met the definition for MAFLD but not NAFLD had a 1.7-fold higher risk of all-cause mortality (HR 1.66, 95% CI 1.19-2.32). Estimates for all-cause mortality were higher for those with advanced fibrosis and MAFLD than for those with advanced fibrosis and NAFLD. In this US population-based study, MAFLD was associated with an increased risk of all-cause mortality, while NAFLD demonstrated no association with all-cause mortality after adjusting for metabolic risk factors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jiejie完成签到,获得积分10
刚刚
sun完成签到,获得积分10
1秒前
4秒前
嚣张的豆豆完成签到,获得积分10
4秒前
繁荣的念双完成签到,获得积分10
5秒前
共享精神应助米九采纳,获得10
5秒前
小蘑菇应助小羊要加油采纳,获得10
6秒前
完美世界应助研友_LaV1xn采纳,获得10
7秒前
leijh123完成签到,获得积分20
8秒前
xv完成签到,获得积分10
8秒前
CGBY完成签到 ,获得积分10
9秒前
科研通AI2S应助科研通管家采纳,获得30
11秒前
orixero应助科研通管家采纳,获得10
11秒前
wanci应助科研通管家采纳,获得10
12秒前
Byby应助柚屿采纳,获得30
12秒前
12秒前
研友_VZG7GZ应助科研通管家采纳,获得10
12秒前
香蕉觅云应助科研通管家采纳,获得10
12秒前
科研通AI2S应助科研通管家采纳,获得10
12秒前
12秒前
SciGPT应助科研通管家采纳,获得10
12秒前
Mobius完成签到,获得积分10
12秒前
13秒前
15秒前
训仔完成签到,获得积分10
15秒前
16秒前
18秒前
20秒前
赘婿应助dudu采纳,获得10
20秒前
20秒前
科目三应助AmyHu采纳,获得10
21秒前
江上钓太公完成签到,获得积分10
23秒前
斯文败类应助哈哈哈哈采纳,获得10
24秒前
niumi190发布了新的文献求助20
25秒前
礽粥粥发布了新的文献求助10
25秒前
瘦瘦的睫毛膏完成签到,获得积分10
26秒前
27秒前
NexusExplorer应助caikeke采纳,获得10
28秒前
李健应助QWE采纳,获得10
29秒前
万能图书馆应助雪雪子采纳,获得10
29秒前
高分求助中
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
CLSI EP47 Evaluation of Reagent Carryover Effects on Test Results, 1st Edition 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
Retention of title in secured transactions law from a creditor's perspective: A comparative analysis of selected (non-)functional approaches 500
"Sixth plenary session of the Eighth Central Committee of the Communist Party of China" 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3055401
求助须知:如何正确求助?哪些是违规求助? 2712227
关于积分的说明 7430195
捐赠科研通 2357037
什么是DOI,文献DOI怎么找? 1248528
科研通“疑难数据库(出版商)”最低求助积分说明 606737
版权声明 596093